TABLE 5.
THE ASSOCIATION BETWEEN INCREASING LEVELS OF DNA METHYLATION ACROSS ARG2 LOCI AND PERCENT CHANGE IN FRACTIONAL CONCENTRATION OF NITRIC OXIDE
| Combined* (n = 876) |
Children with Asthma† (n = 120) |
Children with No Asthma† (n = 756) |
|||||
| No. of Methylated ARG2 Loci | % Difference | 95% Confidence Interval | % Difference | 95% Confidence Interval | % Difference | 95% Confidence Interval | Pint* |
| 0–1 | Reference | Reference | Reference | 0.03 | |||
| 2 | −12.3 | (−22.6 to −0.6) | −20.1 | (−45.3 to 16.7) | −9.7 | (−20.6 to 2.8) | |
| 3 | −12.5 | (−22.5 to −1.3) | −42.3 | (−60.3 to −16.3) | −6.6 | (−17.5 to 5.7) | |
| Trend | −5.6 | (−10.9 to 0.1) | −24.6 | (−37.5 to −9.5) | −2.3 | (−8 to 3.7) | 0.007 |
P value testing the interaction between ARG2 number of methylated loci and asthma status in model adjusted for age, sex, race, plate, town, month of DNA collection, asthma medicine used, education, and asthma.
Analyses are adjusted for age, sex, race, plate, town, month of DNA collection, asthma medicine used, and education.